Israeli-led consortium publishes cell atlas of the human body: The first draft of the Human Cell Atlas, a comprehensive database of human cells, has been published. The project, launched in 2016, aims to create comprehensive reference maps of all human cells as a basis for understanding human health and for diagnosing, monitoring, and treating disease. https://lnkd.in/gD4idDbZ
Behrooz Parhami’s Post
More Relevant Posts
-
SenCID enables the reconstruction of senescent trajectories under normal aging, chronic diseases, and COVID-19. Additionally, when applied to single-cell Perturb-seq data, SenCID helps reveal a hierarchy of senescence modulators. Overall, SenCID is an essential tool for precise single-cell analysis of cellular senescence, enabling targeted interventions against senescent cells.
-
Reveal for Liver Disease is setting a new benchmark in early liver disease detection. By utilizing complex datasets from millions of patients, it creates enhanced diagnostic capabilities compared to traditional methods. Dive into the underlying tech and data making it happen. https://hubs.ly/Q02YKhQt0 #LiverDisease #EarlyDetection #MASH #MASLD
-
Instructor in Clinical Investigations -- The Rockefeller University - Stavros Niarchos Foundation Scholar
Excited to see our work featured! In the post below, you can read about the cutting-edge methods we developed to uncover surprising new insights into Huntington’s disease. #HuntingtonsDisease #NeuroscienceResearch #NeurodegenerativeDisorders #RockefellerScience #TeamScience #yearinreview
Cutting-edge methods from the Heintz lab yielded surprising insights into Huntington’s disease. The findings provide potential targets for therapeutic interventions. #RockefellerScience #yearinreview
-
R&D and Translational Science Lead | Program Strategy | Rare Disease | Precision Medicine | Neuroscience | Organoids | in vitro modeling
iPSCs platform to model rare diseases, Part I SLC6A1 Connect
-
Technology executive and entrepreneur. Three exits. Leadership roles at Leidos, Stanford Health, and Allina, among others.
By leveraging data from millions of patient records, our team has developed a sophisticated risk prediction #AI model that goes beyond traditional liver disease screening indicators. What's our approach? It's worth a few minutes to read. Andrei shares how we apply disciplined analytical methods to uncover subtle patterns that may indicate early-stage liver disease. This innovative risk stratification should help flag patients months or years earlier than conventional diagnosis methods.
Reveal for Liver Disease is setting a new benchmark in early liver disease detection. By utilizing complex datasets from millions of patients, it creates enhanced diagnostic capabilities compared to traditional methods. Dive into the underlying tech and data making it happen. https://hubs.ly/Q02YKhQt0 #LiverDisease #EarlyDetection #MASH #MASLD
-
The Human Cell Atlas - establishing a benchmark for detecting and understanding the changes that underlie health and disease https://lnkd.in/dvSaK9x8 #healthspan #longevity #rejuvenation
-
Read about the innovative approaches that Dr Jiao Jiao Li and Dr Gang Liu are using to understanding underexplored diseases, in the hope of finding curative treatment options in the future. https://lnkd.in/gZGRZa7k
-
A new blog post details how StressMarq's #Tau (K18) Delta K280 PFFs (SPR-477) were utilized in the development of a near-infrared fluorescence probe for use in the early detection of soluble #AmyloidBeta aggregates in #Alzheimer's disease. Read it here: https://bit.ly/3NdZI6A